<DOC>
	<DOCNO>NCT01256476</DOCNO>
	<brief_summary>Randomized , double-blind , double-dummy , 12-week , active-controlled study pitavastatin 4 mg daily ( QD ) vs. pravastatin 40 mg daily ( QD ) subject primary hyperlipidemia mixed dyslipidemia .</brief_summary>
	<brief_title>Prevail-Us : A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Male female subject primary hypercholesterolemia mixed dyslipidemia ≥18 ≤80 year age time consent Plasma Lowdensity lipoprotein cholesterol ( LDLC ) ≥130 milligram per deciliter ( mg/dL ) ≤220 mg/dL triglyceride ( TG ) level ≤400 mg/dL Homozygous familial hypercholesterolemia Any condition may cause secondary dyslipidemia Uncontrolled diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>